Cite
Fully constrained acetabular liner vs. dual mobility hip joint in the surgical treatment of metastatic bone disease of the hip: study protocol for a randomized, open-label, two-arm, non-inferiority trial evaluating the post-operative hip dislocation rate.
MLA
Iljazi, Afrim, et al. “Fully Constrained Acetabular Liner vs. Dual Mobility Hip Joint in the Surgical Treatment of Metastatic Bone Disease of the Hip: Study Protocol for a Randomized, Open-Label, Two-Arm, Non-Inferiority Trial Evaluating the Post-Operative Hip Dislocation Rate.” Trials, vol. 24, no. 1, Mar. 2023, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s13063-023-07237-9.
APA
Iljazi, A., Sørensen, M. S., Weber, K. S., Villadsen, A., Eriksson, F., & Petersen, M. M. (2023). Fully constrained acetabular liner vs. dual mobility hip joint in the surgical treatment of metastatic bone disease of the hip: study protocol for a randomized, open-label, two-arm, non-inferiority trial evaluating the post-operative hip dislocation rate. Trials, 24(1), 1–7. https://doi.org/10.1186/s13063-023-07237-9
Chicago
Iljazi, Afrim, Michala Skovlund Sørensen, Kolja Sebastian Weber, Allan Villadsen, Frank Eriksson, and Michael Mørk Petersen. 2023. “Fully Constrained Acetabular Liner vs. Dual Mobility Hip Joint in the Surgical Treatment of Metastatic Bone Disease of the Hip: Study Protocol for a Randomized, Open-Label, Two-Arm, Non-Inferiority Trial Evaluating the Post-Operative Hip Dislocation Rate.” Trials 24 (1): 1–7. doi:10.1186/s13063-023-07237-9.